Category - Executive Moves

Executive Moves

Hepion expands SAB with appointments of four liver disease KOLs

Hepion Pharmaceuticals (NASDAQ:HEPA) added four new internationally recognized thought leaders to its scientific advisory board (SAB), effective immediately. These new members, who bring decades of liver disease...

March 30, 2023

Executive Moves

OpSens names John Hannigan as CFO

OpSens (TSX:OPS; OTCQX:OPSSF) appointed John Hannigan as CFO, effective immediately. Mr. Hannigan is a highly experienced financial executive with more than 22 years of proven financial expertise with domestic and...

March 27, 2023

Executive Moves

Dylan Dupuis joins ROTH MKM healthcare research team

Dylan Dupuis, Ph.D., has joined ROTH MKM’s healthcare research team as managing director, senior research analyst covering biotechnology. His research coverage is expected to include micro-cap and small-cap...

March 13, 2023

Executive Moves

Heron names renowned healthcare investor Kevin Kotler to the board

Heron Therapeutics (NASDAQ:HRTX) appointed three new directors to the board, including Kevin Kotler, a renowned healthcare investor, founder and portfolio manager of Broadfin Capital. Mr. Kotler has over 30 years of...

February 24, 2023

Executive Moves

Elucid names Scott Burger as CCO

Elucid, a closely-held medical technology company providing physicians with AI-powered imaging analysis software to characterize cardiovascular disease, appointed Scott Burger as chief commercial officer. His...

January 26, 2023

Executive Moves

Raymond James adds 3 senior bankers to healthcare practice

Raymond James Ltd. (CNW Group/Raymond James Ltd.) Raymond James again expanded its healthcare investment banking practice with the addition of three senior bankers. Joining the firm as managing directors are Jeff...

January 12, 2023

Executive Moves

Soricimed appoints leading cancer researcher Dr. Siqing Fu to SAB

Soricimed Biopharma appointed Dr. Siqing Fu, a North American leader in cancer research, to its scientific advisory board. Dr. Fu has more than 20 years of experience in cancer research and is currently a professor in...

December 14, 2022

Executive Moves

Ripple Therapeutics elevates director Dr. Jonathan Talamo to chairman

Closely-held Ripple Therapeutics appointed Jonathan Talamo, M.D., currently a member of the board, to be chairman. Dr. Talamo is internationally known as an experienced surgeon and thought leader in ophthalmology, with...

November 29, 2022

Executive Moves

JD Finley named interim CEO of Palisade Bio

Palisade Bio (NASDAQ:PALI) named JD Finley, CFO, as interim CEO, replacing Thomas Hallam, Ph.D., effective Oct. 10. In a statement, James Neal, chairman of Palisade, said Dr. Hallam was “instrumental in the development...

October 11, 2022

Executive Moves

Kumaraguru Raja joins ROTH healthcare research team

Kumaraguru Raja, Ph.D., joined ROTH Capital Partners healthcare research team, as managing director, senior research analyst covering biotechnology. His research coverage is expected to include micro-cap and small-cap...

October 11, 2022

Category - Executive Moves

Hepion expands SAB with appointments of four liver disease KOLs

OpSens names John Hannigan as CFO

Dylan Dupuis joins ROTH MKM healthcare research team

Heron names renowned healthcare investor Kevin Kotler to the board

Elucid names Scott Burger as CCO

Raymond James adds 3 senior bankers to healthcare practice

Soricimed appoints leading cancer researcher Dr. Siqing Fu to SAB

Ripple Therapeutics elevates director Dr. Jonathan Talamo to chairman

JD Finley named interim CEO of Palisade Bio

Kumaraguru Raja joins ROTH healthcare research team

General

More